[go: up one dir, main page]

EP1539998A4 - Methodes et compositions pour synthese de molecules d'acides nucleiques a l'aide de sites de reconnaissance multiples - Google Patents

Methodes et compositions pour synthese de molecules d'acides nucleiques a l'aide de sites de reconnaissance multiples

Info

Publication number
EP1539998A4
EP1539998A4 EP03741892A EP03741892A EP1539998A4 EP 1539998 A4 EP1539998 A4 EP 1539998A4 EP 03741892 A EP03741892 A EP 03741892A EP 03741892 A EP03741892 A EP 03741892A EP 1539998 A4 EP1539998 A4 EP 1539998A4
Authority
EP
European Patent Office
Prior art keywords
synthesis
compositions
methods
nucleic acid
acid molecules
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP03741892A
Other languages
German (de)
English (en)
Other versions
EP1539998A2 (fr
Inventor
Jonathan D Chesnut
John Carrino
Louis Leong
Knut Madden
Martin Gleeson
James Fan
Michael A Brasch
David Cheo
James L Hartley
Devon R N Byrd
Gary F Temple
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Life Technologies Corp
Original Assignee
Invitrogen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Invitrogen Corp filed Critical Invitrogen Corp
Publication of EP1539998A2 publication Critical patent/EP1539998A2/fr
Publication of EP1539998A4 publication Critical patent/EP1539998A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/64—General methods for preparing the vector, for introducing it into the cell or for selecting the vector-containing host
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/66—General methods for inserting a gene into a vector to form a recombinant vector using cleavage and ligation; Use of non-functional linkers or adaptors, e.g. linkers containing the sequence for a restriction endonuclease
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/10—Plasmid DNA
    • C12N2800/108—Plasmid DNA episomal vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/30—Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/70—Vectors containing special elements for cloning, e.g. topoisomerase, adaptor sites
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Mycology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
EP03741892A 2002-06-05 2003-06-05 Methodes et compositions pour synthese de molecules d'acides nucleiques a l'aide de sites de reconnaissance multiples Withdrawn EP1539998A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US38561302P 2002-06-05 2002-06-05
US385613P 2002-06-05
PCT/US2003/018036 WO2003103600A2 (fr) 2002-06-05 2003-06-05 Methodes et compositions pour synthese de molecules d'acides nucleiques a l'aide de sites de reconnaissance multiples

Publications (2)

Publication Number Publication Date
EP1539998A2 EP1539998A2 (fr) 2005-06-15
EP1539998A4 true EP1539998A4 (fr) 2007-10-31

Family

ID=29736108

Family Applications (1)

Application Number Title Priority Date Filing Date
EP03741892A Withdrawn EP1539998A4 (fr) 2002-06-05 2003-06-05 Methodes et compositions pour synthese de molecules d'acides nucleiques a l'aide de sites de reconnaissance multiples

Country Status (3)

Country Link
EP (1) EP1539998A4 (fr)
AU (1) AU2003273995A1 (fr)
WO (1) WO2003103600A2 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6143557A (en) 1995-06-07 2000-11-07 Life Technologies, Inc. Recombination cloning using engineered recombination sites
US6720140B1 (en) 1995-06-07 2004-04-13 Invitrogen Corporation Recombinational cloning using engineered recombination sites
CA2307016A1 (fr) 1997-10-24 1999-05-06 Life Technologies, Inc. Clonage recombinatoire au moyen d'acides nucleiques possedant des sites de recombinaison
US7351578B2 (en) 1999-12-10 2008-04-01 Invitrogen Corp. Use of multiple recombination sites with unique specificity in recombinational cloning
DE60042969D1 (de) 1999-03-02 2009-10-29 Life Technologies Corp Zubereitungen und methoden zur verwendung in rekombinatorischem klonen von nukleinsäuren
NZ553687A (en) 2000-03-30 2010-03-26 Whitehead Biomedical Inst RNA sequence-specific mediators of RNA interference
US7198924B2 (en) 2000-12-11 2007-04-03 Invitrogen Corporation Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites
TR200401292T3 (tr) 2000-12-01 2004-07-21 Max@Planck@Gesellschaft�Zur�F�Rderung�Der�Wissenschaften RNAÁgirişimineÁyolÁaçanÁküçükÁRNAÁmolekülleri
US8729036B2 (en) 2002-08-07 2014-05-20 University Of Massachusetts Compositions for RNA interference and methods of use thereof
ATE469984T1 (de) 2003-12-01 2010-06-15 Life Technologies Corp Rekombinationsstellen enthaltende nukleinsäuremoleküle und verfahren zur verwendung davon
CN1981039A (zh) * 2004-05-10 2007-06-13 巴斯福植物科学有限公司 组装多表达构建体的方法
US7622252B2 (en) 2005-06-10 2009-11-24 Baylor College Of Medicine Generation of minicircle DNA with physiological supercoiling
BR112012011576A2 (pt) 2009-10-16 2015-09-15 Baylor College Medicine dna de minicírculos superenrolados para aplicações de terapia genética
FR3028527A1 (fr) 2014-11-13 2016-05-20 Pivert Identification de facteurs de transcription de yarrowia lipolytica

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5888732A (en) * 1995-06-07 1999-03-30 Life Technologies, Inc. Recombinational cloning using engineered recombination sites

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8835601A (en) * 2000-08-21 2002-03-04 Invitrogen Corp Methods and reagents for molecular cloning
AU2003209054A1 (en) * 2002-02-07 2003-09-02 Discovery Genomics, Inc. Factors for angiogenesis, vasculogenesis, cartilage formation, bone formation and methods of use thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5888732A (en) * 1995-06-07 1999-03-30 Life Technologies, Inc. Recombinational cloning using engineered recombination sites

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
SHUMAN STEWART: "Novel approach to molecular cloning and polynucleotide synthesis using vaccinia DNA topoisomerase", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY OF BIOLOCHEMICAL BIOLOGISTS, BIRMINGHAM,, US, vol. 269, no. 51, 23 December 1994 (1994-12-23), pages 32678 - 32684, XP002164562, ISSN: 0021-9258 *
ZECHIEDRICH E LYNN ET AL: "Topoisomerase IV, not gyrase, decatenates products of site-specific recombination in Escherichia coli", GENES AND DEVELOPMENT, vol. 11, no. 19, 1997, pages 2580 - 2592, XP002450742, ISSN: 0890-9369 *

Also Published As

Publication number Publication date
AU2003273995A8 (en) 2003-12-22
WO2003103600A3 (fr) 2004-10-07
AU2003273995A1 (en) 2003-12-22
WO2003103600A2 (fr) 2003-12-18
EP1539998A2 (fr) 2005-06-15

Similar Documents

Publication Publication Date Title
AU2002318386A1 (en) Methods for characterization of nucleic acid molecules
AU2003287299A1 (en) Process for concentration of macromolecules
AU2003270310A8 (en) Compositions and methods for synthesizing nucleic acids
EP1451344A4 (fr) Compositions et methodes destinees a etre utilisees pour isoler des molecules d'acide nucleique
AU2002365811A1 (en) Methods for the selection and cloning of nucleic acid molecules free of unwanted nucleotide sequence alterations
AU2003230957A8 (en) Quantitation of biological molecules
AU2003273995A8 (en) Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites
EP1390394A4 (fr) Compositions et procedes destines au clonage recombinant de molecules d'acides nucleiques
AU2003280603A8 (en) Method of amplifying nucleic acid
AU2003243541A8 (en) Methods and compositions relating to labeled rna molecules that reduce gene expression
AU2003260291A8 (en) Proximity-aided synthesis of templated molecules
AU2003303588A1 (en) Methods and compositions for sequencing nucleic acid molecules
AU2003250506A8 (en) Method for the characteristation of nucleic acid molecules
IL173107A0 (en) Compositions and methods for purifying and crystallizing molecules of interest
EG24152A (en) Novel method for the synthesis of s-indoline-2-carboxylic acid and application thereof in synthesis of perindopril
AU2003211867A1 (en) Novel method of highly sensitive nucleic acid analysis
AU2002306850A1 (en) Methods and reagents for decreasing clinical reaction to allergy
AU2003268478A1 (en) Cardiolipin molecules and method of synthesis
AU2003232036A8 (en) Nanoarchaeum nucleic acid molecule
SI1527176T1 (sl) Nadaljnje nove oblike interferirajoäśih molekul rna
GB0320415D0 (en) Analysis of macromolecules
HK1079551A (en) Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites
GB0212853D0 (en) Separation of molecules
EP1614750A4 (fr) Nouvel acide nucleique a peptide fonctionnel et procede de production associe
GB2392746B (en) Comparison of molecules using field points

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20050105

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK

REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1079551

Country of ref document: HK

RIN1 Information on inventor provided before grant (corrected)

Inventor name: TEMPLE, GARY, F.

Inventor name: BYRD, DEVON, R.N.

Inventor name: HARTLEY, JAMES, L.

Inventor name: CHEO, DAVID

Inventor name: BRASCH, MICHAEL, A.

Inventor name: FAN, JAMES

Inventor name: GLEESON, MARTIN

Inventor name: MADDEN, KNUT

Inventor name: LEONG, LOUIS

Inventor name: CARRINO, JOHN

Inventor name: CHESNUT, JONATHAN, D.

A4 Supplementary search report drawn up and despatched

Effective date: 20070927

17Q First examination report despatched

Effective date: 20081021

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: LIFE TECHNOLOGIES CORPORATION

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20090603

R18D Application deemed to be withdrawn (corrected)

Effective date: 20090505

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1079551

Country of ref document: HK